OTCMKTS:TRSSF TerrAscend - TRSSF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding TerrAscend Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $1.52 0.00 (0.00%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.49▼$1.5950-Day Range$1.02▼$2.2452-Week Range$1.00▼$6.06Volume270,895 shsAverage Volume100,140 shsMarket Capitalization$382.83 millionP/E RatioN/ADividend YieldN/APrice Target$3.57 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest TerrAscend MarketRank™ ForecastAnalyst RatingModerate Buy2.63 Rating ScoreUpside/Downside134.6% Upside$3.57 Price TargetShort InterestHealthy0.21% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.14) to ($0.10) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.96 out of 5 stars 3.3 Analyst's Opinion Consensus RatingTerrAscend has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.57, TerrAscend has a forecasted upside of 134.6% from its current price of $1.52.Amount of Analyst CoverageTerrAscend has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.21% of the outstanding shares of TerrAscend have been sold short.Short Interest Ratio / Days to CoverTerrAscend has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in TerrAscend has recently increased by 4.65%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldTerrAscend does not currently pay a dividend.Dividend GrowthTerrAscend does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRSSF. Previous Next 1.8 News and Social Media Coverage News SentimentTerrAscend has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for TerrAscend this week, compared to 2 articles on an average week.Search Interest1 people have searched for TRSSF on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added TerrAscend to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, TerrAscend insiders have not sold or bought any company stock.Percentage Held by Insiders44.32% of the stock of TerrAscend is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.04% of the stock of TerrAscend is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for TerrAscend are expected to grow in the coming year, from ($0.14) to ($0.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of TerrAscend is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of TerrAscend is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTerrAscend has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About TerrAscend (OTCMKTS:TRSSF) StockTerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.Read More Receive TRSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter. Email Address TRSSF Stock News HeadlinesJanuary 30, 2023 | finance.yahoo.comTerrAscend Closes on Acquisition of High-Performing Dispensary in MarylandJanuary 19, 2023 | finance.yahoo.comWana Brands Partners with TerrAscend to Bring its Best-In-Class Edibles to New Jersey and to Expand its Existing Line-Up in MarylandFebruary 4, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 11, 2023 | finance.yahoo.comTerrAscend to Participate in the ATB Capital Markets 11th Annual Institutional Investor ConferenceDecember 21, 2022 | finance.yahoo.comTerrAscend Announces Amendment of Pennsylvania Credit AgreementDecember 3, 2022 | benzinga.comWhere To Buy Legal Weed These Days: Five More Shops Launch Cannabis Sales In These StatesDecember 2, 2022 | finance.yahoo.comTerrAscend Appoints Seasoned Finance Professional, Ira Duarte, to Board of DirectorsDecember 2, 2022 | finance.yahoo.comTerrAscend and Cookies Celebrate the Grand Opening of Cookies JacksonFebruary 4, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 2, 2022 | benzinga.comTerrAscend Appoints Ira Duarte To Board Of DirectorsNovember 30, 2022 | benzinga.comTerrAscend Reduces Outstanding Debt By $30MNovember 30, 2022 | finance.yahoo.comTerrAscend Reduces Outstanding Debt by US$30 MillionNovember 15, 2022 | finance.yahoo.comTerrAscend Reports Third Quarter 2022 Financial ResultsNovember 14, 2022 | benzinga.comTerrAscend Reports 3Q 2022 Financial Results: Net Revenue Up 36.4% YoYNovember 10, 2022 | finance.yahoo.comIs a Surprise Coming for TerrAscend (TRSSF) This Earnings Season?October 28, 2022 | benzinga.comWhat's In The Cards For These Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings SeasonOctober 27, 2022 | finance.yahoo.comTERRASCEND TO HOST THIRD QUARTER 2022 EARNINGS CONFERENCE CALLOctober 26, 2022 | msn.comCanopy Growth Transfers Its TerrAscend Assets To Canopy USA CompanyOctober 25, 2022 | msn.comCanopy Growth speeds up entry to U.S. cannabis market instead of waiting for federal ban to be liftedOctober 20, 2022 | fool.com3 Stocks to Invest in If Maryland Approves Adult-Use Cannabis Sales - The Motley FoolOctober 17, 2022 | morningstar.comCannabis M&A cools but deals remain on the table despite scuttled Verano acquisition, analyst says - MorningstarOctober 16, 2022 | fool.comWhich Company Will Become Profitable First: Canopy Growth or Aurora Cannabis? - The Motley FoolOctober 12, 2022 | marketwatch.comCannabis company TerrAscend secures $45.5 mln loan with 12.8% interest rate - MarketWatchOctober 12, 2022 | nasdaq.comWhich Cannabis Stocks Would Benefit Most From U.S. Federal Legalization? - NasdaqOctober 12, 2022 | finance.yahoo.comTerrAscend Announces Closing of US$45.5 Million Non-Brokered Debt Financing - Yahoo FinanceOctober 12, 2022 | finance.yahoo.comTerrAscend Announces Closing of US$45.5 Million Non-Brokered Debt FinancingOctober 12, 2022 | finance.yahoo.comPelorus Equity Group Closes US$45.5 Million Debt Financing with TerrAscendSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TRSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter. Email Address TRSSF Company Calendar Last Earnings11/14/2022Today2/03/2023Next Earnings (Estimated)3/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Agricultural production - crops Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRSSF CUSIPN/A CIK1778129 Webwww.terrascend.com Phone(855) 837-7295FaxN/AEmployees742Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.57 High Stock Price Forecast$5.50 Low Stock Price Forecast$2.00 Forecasted Upside/Downside+134.6%Consensus RatingModerate Buy Rating Score (0-4)2.63 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($1.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.11 million Net Margins-143.67% Pretax Margin-146.26% Return on Equity-8.24% Return on Assets-3.88% Debt Debt-to-Equity Ratio0.77 Current Ratio0.66 Quick Ratio0.37 Sales & Book Value Annual Sales$210.42 million Price / Sales1.82 Cash FlowN/A Price / Cash FlowN/A Book Value$1.20 per share Price / Book1.27Miscellaneous Outstanding Shares251,860,000Free Float140,237,000Market Cap$382.83 million OptionableNot Optionable BetaN/A Key ExecutivesZiad GhanemPresident & Chief Operating OfficerKeith StaufferChief Financial OfficerDavid WheelerChief Information Officer & Senior Vice PresidentDaniel FoleyTreasurer & Senior Vice PresidentJared AndersonSenior Vice President-Finance & StrategyKey CompetitorsVeranoOTCMKTS:VRNOFCue HealthNASDAQ:HLTHFoghorn TherapeuticsNASDAQ:FHTXOmega TherapeuticsNASDAQ:OMGAPepGenNASDAQ:PEPGView All Competitors TRSSF Stock - Frequently Asked Questions Should I buy or sell TerrAscend stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last twelve months. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TRSSF shares. View TRSSF analyst ratings or view top-rated stocks. What is TerrAscend's stock price forecast for 2023? 8 equities research analysts have issued 12 month price targets for TerrAscend's stock. Their TRSSF share price forecasts range from $2.00 to $5.50. On average, they anticipate the company's share price to reach $3.57 in the next twelve months. This suggests a possible upside of 134.6% from the stock's current price. View analysts price targets for TRSSF or view top-rated stocks among Wall Street analysts. How have TRSSF shares performed in 2023? TerrAscend's stock was trading at $1.13 on January 1st, 2023. Since then, TRSSF stock has increased by 34.5% and is now trading at $1.52. View the best growth stocks for 2023 here. When is TerrAscend's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 14th 2023. View our TRSSF earnings forecast. How were TerrAscend's earnings last quarter? TerrAscend Corp. (OTCMKTS:TRSSF) issued its earnings results on Monday, November, 14th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.13. The firm earned $67.03 million during the quarter, compared to analyst estimates of $67.84 million. TerrAscend had a negative net margin of 143.67% and a negative trailing twelve-month return on equity of 8.24%. What is TerrAscend's stock symbol? TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF." How do I buy shares of TerrAscend? Shares of TRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is TerrAscend's stock price today? One share of TRSSF stock can currently be purchased for approximately $1.52. How much money does TerrAscend make? TerrAscend (OTCMKTS:TRSSF) has a market capitalization of $382.83 million and generates $210.42 million in revenue each year. The company earns $3.11 million in net income (profit) each year or ($1.34) on an earnings per share basis. How many employees does TerrAscend have? The company employs 742 workers across the globe. How can I contact TerrAscend? TerrAscend's mailing address is PO Box 43125, Mississauga, ON L5B. The official website for the company is www.terrascend.com. The company can be reached via phone at (855) 837-7295 or via email at ir@terrascend.com. This page (OTCMKTS:TRSSF) was last updated on 2/4/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.